Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort.
Saved in:
| Title: | Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort. |
|---|---|
| Authors: | Claudepierre, Pascal1 (AUTHOR), Van den Bosch, Filip2 (AUTHOR), Sarzi‐Puttini, Piercarlo3 (AUTHOR), Vastesaeger, Nathan4 (AUTHOR), Govoni, Marinella5 (AUTHOR), Kachroo, Sumesh6 (AUTHOR) sumesh.kachroo@merck.com |
| Source: | International Journal of Rheumatic Diseases. Jun2019, Vol. 22 Issue 6, p995-1001. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17561841 |
|---|---|
| DOI: | 10.1111/1756-185X.13526 |
